Rating History for Atrium Therapeutics (RNA) by Leerink

More Stocks Rated by Leerink | Latest Ratings for RNA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/15/2026 Joseph Schwartz New Coverage Outperform
(N/A)		 25.00
(N/A)		 13.27
(12.37)		 -6.78% Details